The CHIP mutations mostly occur in the DNMT3A, TET2, PPM1D, ASXL1 and TP53 genes (29), whereas pathogenic variants of breast cancer were most prevalent in TP53, PIK3CA, MAP3KA1, CDH1, and PTEN (32). This evidence concerns the gene TET2 and breast carcinoma.